Table 1 Gene Ontology analysis based on Pc data. Genes having Pc < − 0.2 were considered. For cumulative Pc analysis, the 3 individual Pc were added and the genes within the 5th percentile of those with higher cumulative Pc were considered

 positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343)

11.63

 myeloid leukocyte activation (GO:0002274)

3.33

 myeloid leukocyte differentiation (GO:0002573)

3.28

 positive regulation of T cell activation (GO:0050870)

3.21

 cytokine production (GO:0001816)

3.08

 positive regulation of leukocyte cell-cell adhesion (GO:1903039)

3.02

 positive regulation of leukocyte proliferation (GO:0070665)

2.94

 cell activation involved in immune response (GO:0002263)

2.7

 regulation of T cell activation (GO:0050863)

2.69

 regulation of leukocyte cell-cell adhesion (GO:1903037)

2.67

 neuronal action potential propagation (GO:0019227)

13.51

 action potential propagation (GO:0098870)

13.51

 plasma membrane organization (GO:0007009)

3.82

 lymphocyte differentiation (GO:0030098)

2.66

 mononuclear cell differentiation (GO:1903131)

2.46

 leukocyte differentiation (GO:0002521)

2.36

 lymphocyte activation (GO:0046649)

2.35

 leukocyte activation (GO:0045321)

2.22

 hemopoiesis (GO:0030097)

2.1

 hematopoietic or lymphoid organ development (GO:0048534)

1.97

 mitotic G2/M transition checkpoint (GO:0044818)

6

 negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)

5.24

 negative regulation of cell cycle G2/M phase transition (GO:1902750)

4.68

 regulation of G2/M transition of mitotic cell cycle (GO:0010389)

4.64

 regulation of cell cycle G2/M phase transition (GO:1902749)

3.9

 negative regulation of mitotic cell cycle phase transition (GO:1901991)

3.15

 negative regulation of cell cycle phase transition (GO:1901988)

3.12

 regulation of mitotic cell cycle phase transition (GO:1901990)

2.79

 regulation of cell cycle phase transition (GO:1901987)

2.56

 mitotic cell cycle (GO:0000278)

2.06

 mammary gland epithelium development (GO:0061180)

5.14

 cellular modified amino acid metabolic process (GO:0006575)

3.59

 sulfur compound metabolic process (GO:0006790)

2.95

 glycerophospholipid metabolic process (GO:0006650)

2.76

 phospholipid metabolic process (GO:0006644)

2.59

 cellular lipid metabolic process (GO:0044255)

2.4

 organophosphate metabolic process (GO:0019637)

2.37

 monocarboxylic acid metabolic process (GO:0032787)

2.26

 carboxylic acid metabolic process (GO:0019752)

2.19

 organic acid metabolic process (GO:0006082)

2.18